Sunteți pe pagina 1din 2

Corporate Offie : Mahendra Industrial Estate,

Ground Floor, Pfot [Vo. 109-D, Road No,. 29,


Sion (East), Mumbai - 1OO CIZZ. (Inclia)
Tel.: (122-24O7 22q9 / Z4At 9O25 (30 r"ines)
Fax: Ct22-24O7 3462 | 24o7 Ot44

=t

tl= Aarti Drugs Limited

Email ; audit@aartidrugs.com
websi,te : www.aartidrugs. com

Manufacturers of : Bulk Drugs & Chemicals

CIN

No.

: U!7O60MH19g4pLCO5S433

Ref. No: ADL/SE-2M t2016

Date :

Sth

February,2016

To,
Listi ng/Compl iance Department

BSE LTD.
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai - 400 001.
BSE CODE -524348

To,

Listing/Complia nce Departmeirt


National Stock Exchange of
India Limitecl
"Exchange Plaza", Plot No. C/1,
G Block Banclra-Kurla Complex,
Bandra (E), tvlumbai - 400 051.
NSE GODE:I\ARTTDRUGS

Dear Sir/Madam,

Please find enclosed herewith copy of press release issued by flhe


company on Sth February,
2016.
Kindly take the note of the above.

Thanking You
Yours faithfully,
For AARTI DRUGS LtM|TED

HARSHIT M. SAVLA
JT. MANAGING DIRECTOR
Encl: as above.

Regd. office

Plot No. N-198, MIDC, Tarapur, Tal-palghar, Dist.palghar - a01 506.(MH)

Corporate Office : Mahendra Industrfal Estate,


Ground Floor, Plot No. 1Og-D, Road No. 29,

=D

4= Aarti Drugs Limited


Manufacturens of : Bulk Drugs & Chemicals

Sion (lEast), Mumbai

- 400 AZZ. (India)

Fax: O22-2407 3462

/ 24OI9025 (30 Lines)


| 2407 0t44

'tel.: 022-2407 2249

Email: audit@aartidrugs.com
website: www.aartidrugs.com
CIN Nrc. : 137060MH1984p1C055433

Press release for Dec'20,15:


Macroeconomic factors that are unfavourable to global trade,
continues to impact the expor"t
sales and indirectly the domestic sales, which are folated to formrulation
exports. tn spite of this,
company has shown good growth in the domestic markets.
Consolidated EBITDA for the period ended Dec' 15 is 129.93 cTores,
up by 3.o7vo, indicating
stable operational efficiency. Profit before tax has gone down on account
of higher depreciation
and interest costs, due to commissioning of vario-us expansion projects. coripany
has taken
swift action to reduce inventory levels to be adaptable to iace current
industry challenges.
Expansion project of anti- diarrheal product went live in Dec'15 quarterwhich
will give boost kr
sales in future. Company seeks to get regulatory approvals for itl
new anti-biotic facility, which
wt-ll-Olve impetus to topline in near future. Company is actively
seeking for re-inspection fronr
USFDA authorities, to restart its USA business.
For AARTI DRUGS LIM|TED

$_

qffi-r-F*
HARSHIT M. SAVLA
JT. MANAGING DIRECTOR

Regd' office : Plot No. N-198, MIDC, Tarapur, Tal-palghar, Dist.palghar - 401 506.(MH)